NCT04032470 Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET)
| NCT ID | NCT04032470 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Boston Scientific Corporation |
| Condition | Essential Tremor |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2019-10-23 |
| Primary Completion | 2029-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2019-10-23 with a primary completion date of 2029-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To compile characteristics of real-world outcomes for Boston Scientific Corporation's commercially approved Deep Brain Stimulation (DBS) Systems, when used according to the applicable Directions for Use, for the treatment of Essential Tremor.
Eligibility Criteria
Inclusion Criteria: * Meets criteria established in the locally applicable Directions for Use (DFU) for Essential Tremor * Is at least 18 years old Exclusion Criteria: * Meets any contraindication in locally applicable Directions for Use
Contact & Investigator
Natalie Bloom Lyons
STUDY DIRECTOR
Boston Scientific Corporation
Frequently Asked Questions
Who can join the NCT04032470 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Essential Tremor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04032470 currently recruiting?
Yes, NCT04032470 is actively recruiting participants. Contact the research team at BSNClinicalTrials@bsci.com for enrollment information.
Where is the NCT04032470 trial being conducted?
This trial is being conducted at Innsbruck, Austria, Ghent, Belgium, Leuven, Belgium, Roeselare, Belgium and 11 additional locations.
Who is sponsoring the NCT04032470 clinical trial?
NCT04032470 is sponsored by Boston Scientific Corporation. The principal investigator is Natalie Bloom Lyons at Boston Scientific Corporation. The trial plans to enroll 500 participants.